[SRNE] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -18.90%
YoY- -32.46%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 122 135 217 110 128 92 74 39.34%
PBT -3,236 -1,241 -943 -906 -3,236 -445 -1,088 106.13%
Tax -3,090 4 4 3 -2,474 2 3 -
NP -1,755 -1,241 -943 -906 -762 -702 -1,088 37.34%
Tax Rate - - - - - - - -
Total Cost 1,877 1,376 1,160 1,016 890 794 1,162 37.46%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -1,438.58 -922.81 -434.35 -822.64 -595.84 -765.39 -1,466.69 -1.27%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -0.14 -0.10 -0.08 -0.09 -0.07 -0.07 -0.11 17.35%
EPS Diluted -0.14 -0.10 -0.08 -0.09 -0.07 -0.07 -0.11 17.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.